Bimekizumab for psoriasis treatment: A Canadian real-world multicenter study.

JAAD Int · 2025 · PMC12269611 · PMID 40677732

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Bionaïve patients showed a trend toward higher PASI responses than bioexperienced patients, but differences were not statistically significant.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.